was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
on individuals and communities. ViiV Healthcare was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009... is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Are you looking for a new challenge in a critical strategic...
GlaxoSmithKline (GSK) is seeking an experienced Associate Director in Sample Management & Automation to join the Data...
Position Summary For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market positioning. Specifically, evidence must be generated and maintained throughout the p...
Head, US Ecosystem Strategy [Communications & Government Affairs (CGA)] Location: Washington, DC The US healthcare system is complex and constantly evolving. GSK collaborates with diverse stakeholders to better understand patient needs ...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of ...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...